Ad Code: Wegovy - Display Banners Conference - Month 3 - ADA - 252712

An abstract presented at the ADA 85th Scientific Sessions showed that obesity telemedicine plus GLP-1 therapy yielded improvements in multiple outcomes.

Obesity drugs were not utilized often in young adults and adolescents despite high complication rates, prompting researchers to call for chronic, holistic care.

A study found plant‑based calorie restriction achieved similar weight loss as standard diets, with added benefits for uric acid and other markers.

Losing at least 5% of body weight reduces liver and visceral fat but decreases muscle mass, underscoring the need for muscle-preserving weight loss strategies.

The PATHWEIGH trial aims to embed structured obesity care into primary care, addressing barriers and boosting clinician confidence and patient outcomes.

The ADA’s 85th Scientific Sessions will highlight breakthroughs in obesity and diabetes care, including GLP-1 therapies, tech advances, and prevention tools.

The ADA 85th Scientific Sessions runs from June 20 to June 23, 2025 and will feature a wealth of presentations on obesity, nutrition, and diabetes care.